• PTO Procedures utilization in a Hatch-Waxman scenario: IPR, reissue, and more;
• Teva v. Sandoz and interim Markman strategies;
• The surge in premature notice filings;
• Federal Circuit and PTO discord on obviousness finding;
• Akamai's impact on method of treatment patents;
• New safe harbor expansions and exceptions;
• Exclusivity concerns for combination products, NCEs, and generics; and
• At-risk launches, injunctions, and damages.
• Oyez, Oyez, Oyez!: Review of Key Supreme Court Cases that May Alter the Course of Paragraph IV Litigation
• Brand Name and Generic Interpretations of The Changing Paradigm for Generic Market Entry: Identifying New Due Diligence Concerns Relative to ANDA Drug Targets and Anticipating New Paragraph IV Challenges
• It's All About Timing: Exploring the Surge in Premature Paragraph IV Notice Filings and Its Consequences
• Teva v. Sandoz -- A Debate on the Standard of Review for Claim Construction: De Novo vs. Deferential
• Exploring the Use of Reissue Applications to Amend Invalidity Findings in The District Courts
• Analyzing the Evolving Utilization of IPR and Other PTO Proceedings in Paragraph IV Litigation: Brand Name and Generic Perspectives
• Understanding the Importance of Abiding by Local Rules: A Magistrate's Perspective
• A View From the Bench: The Judges Speak
• Obviousness, Obliviousness and Obscurity: Exploring New Developments Double-Patenting Type Obviousness and Federal Circuit and PTO Discord on Obvious Findings Relative to Prior Art
• Experts, Problems of Proof, Dispositive Motions and Markman Hearings: Addressing Common Dilemmas Encountered in A Paragraph IV Trial
• Understanding How the Supreme Court's Decision in Limelight v. Akamai Will Impact ANDA Litigation Involving Method of Treatment Patents
• FTC Keynote: Reverse Payment Settlements and Other Antitrust Concerns Impacting Paragraph IV Litigation in the Wake of Actavis -- to be presented by J. Maren Schmidt, Attorney, Health Care Division, Bureau of Competition, Federal Trade Commission
• The Ever Shifting Boundaries of the Safe Harbor: Determining the Scope of 271 (e)(1) Protections Relative to Paragraph IV Litigation Post Classen and Momenta
• New Exclusivity Challenges for Brand Names and Generics: Exploring Their Implications for Paragraph IV Challenges
• The Uncertain Future of At-Risk Launches: A Study of Injunctive Relief, Damages and the Impact of Protonix
• Ethical Considerations for Paragraph IV Matters Before the PTO and District Courts: Looking Beyond Inequitable
In addition, two pre-conference workshops will be offered on September 29, 2014. The first, entitled "PTO Procedures Practice Boot Camp for Paragraph IV Litigators" will be offered from 8:30 am to 12:00 pm, and the second, entitled "May it Please the Court: A Judge’s Perspective on Effectively and Ethically Communicating With the Court In Paragraph IV Matters," will be offered from 2:00 to 5:30 pm.
The agenda for the Paragraph IV Disputes master symposium can be found here. More information regarding the workshops can be found here. A complete brochure for this conference, including an agenda, detailed descriptions of conference sessions, list of speakers, and registration form can be obtained here.
The registration fee for the conference is $2,395 (conference alone), $2,995 (conference and one workshop), or $3,595 (conference and both workshops). Those registering by August 4, 2014 will receive a $400 discount, and those registering by September 8, 2014 will receive a $200 discount. Patent Docs readers who reference the discount code "PD200" will receive $200 off the current price tier when registering. Those interested in registering for the conference can do so here, by e-mailing CustomerService@AmericanConference.com, by calling 1-888-224-2480, or by faxing a registration form to 1-877-927-1563.
Patent Docs is a media partner of the Paragraph IV Disputes master symposium.